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The virulence factors and antibiotic-resistance in enterococci isolated from the 
clinical samples and hospital environment were determined using standard 
microbiological methods. A total of 81 clinical samples and 35 environmental samples 
from a tertiary hospital in Ekiti State, Nigeria, were examined for the presence of 
Enterococcus spp. Species isolated were identified to include: Enterococcus faecalis 
(110), Enterococcus faecium (75), Enterococcus gallinarum (39), Enterococcus durans 
(37) and Enterococcus hirae (33). Enterococccus faecalis has the highest occurrence 
followed by E. faecium, while E. hirae had the least occurrence. The percentage 
prevalence of cytolysin (Cyt) was highest in E. gallinarum (74.4%) followed by E. 
faecalis (68.5%). A total of 49 (44.1%), 19 (48.7%) and 13 (17.3%) among E. faecalis, 
E. gallinarum and E. faecium, respectively, were positive for the combination of 
cytolysin (Cyt) and gelatinase (Gel). The presence of Gel with haemaglutinin (Hea) in 
the isolates was comparably lower than the Cyt and Gel combination. The occurrence 
of the three pathogenic factors is in this decreasing order: E. faecalis 20 (18.0%), E. 
faecium 8 (10.7%) and E. gallinarum 2 (5.1%). The susceptibility of isolates was tested 
against nine antibiotics. All the E. faecium isolates were resistant to cotrimoxazole, 
ampicillin and chloramphenicol while none was resistant to vancomycin. The highest 
resistance was observed against cotrimoxazole followed by erythromycin while the least 
was observed in vancomycin. The highest vancomycin resistance was found among E. 
faecalis (30.6%) followed by E. durans (18.2%). The resistance of Enterococcus spp. 
was minimal to vancomycin, ofloxacin and nitrofurantoin, in increasing order, among 
the tested antibiotics. 





Enterococci are non-spore forming, 
Gram-positive bacteria found mainly in the 
gastrointestinal tract of mammals and other 
warm-blooded animals (Aarestrup et al. 2002). 
Enterococci have natural ability to acquire, 
accumulate, and share genetic elements 
encoding virulence traits and antibiotic 
resistance. They frequently cause a variety of 
human infections. Not only the incidence of 
nosocomially acquired infections has 
dramatically increased but also the therapeutic 
failure due to increasing antimicrobial 
resistance of Enterococcus spp. Enterococci are 
naturally resistant to antibiotics (Murray 1990) 
while they acquire antibiotic resistance and 
spread this to other species (Kühn et al. 2003). 
Multiple antibiotic-resistant enterococci (MRE) 
are a significant challenge for therapeutic 
measures (Huycke et al. 2002; Portenier et al. 
2003). Several virulence factors have been 
identified in enterococci, which among other 
include haemolysin, aggregation substance 
(Agg), enterococcal surface protein (Esp), 
gelatinase and serine protease (Franz et al. 
1999; Busani et al. 2004; Gülhan et al. 2006). 
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Gelatinase (GelE) is an extracellular zinc 
metallo-endopeptidase secreted by enterococci 
(Koch et al. 2004). It has the ability to 
hydrolyze gelatin, casein, haemoglobin and 
other bioactive peptides. The gene (gelE) 
encoding GelE is located on the chromosome 
and is regulated in a cell-density-dependent 
manner (Lopes et al. 2006). The main role of 
gelatinase in enterococcal pathogenesis is to 
provide nutrients to the bacteria by degrading 
host tissue, although they also have some 
function in biofilm formation (Gilmore 2002; 
Mohamed and Huang 2007).  
Agglutination of erythrocytes by bacteria 
is a convenient measure of adherence. It 
contributes to attachment to host cells (Kurl et 
al. 1989; Carvalho and Teixeira 1995) and was 
identified to be caused by thermostable 
compounds of proteineous and non-proteineous 
nature. Haemagglutination-positive E. faecalis 
isolates produced identical results with all 
kinds of erythrocytes tested, suggesting that 
binding was unspecific or caused by the 
presence of different adhesins (Elsner et al. 
2000).  
Haemolysin is one of the virulence 
factors associated with enterococci, it is 
considered to be important as it enhances the 
severity of haemolytic activity and ability of 
the organism (Semedo et al. 2003). Cytolysin 
production is associated with a better ability to 
reach the blood stream and induces septicaemia 
and a fivefold increased risk of acutely terminal 
outcome in patients (Dupont et al. 1998). 
In this study, the level of dissemination 
of virulence factors and antibiotic resistance in 
enterococci recovered from both clinical 
samples and hospital environment was 
determined in a tertiary health care setting in 
Ekiti State, Nigeria. 
 
2. Materials and Methods 
 
2.1 Isolation of Enterococci from Samples 
The clinical and hospital environmental 
samples were collected by sterile cotton swabs 
moistened with sterile distilled water. The 
samples examined included stool (57), wound 
(15), high vaginal swab (9) and bed sheet swab 
(35). The samples were inoculated directly onto 
sterile plates of Bile Aesculin Azide Agar 
(Oxoid) and incubated at 37
o
C for 24 hours. 
Discrete colonies surrounded with dark hallow 
were picked and sub-cultured to get a pure 
culture. Isolates were identified by 
conventional standard methods described by 
Olutiola et al. (2000) and Schleifer and 
Kilpper-Bälz (1984). 
 
2.2 Detection of the Pathogenic Factors 
 
2.2.1 Detection of Gelatine Hydrolysis 
(GelE): The method of Su et al. (1991) was 
used with a slight modification to detect 
gelatinase production among the isolates. 
Briefly, nutrient agar supplemented with 0.4% 
by weight, of gelatin (BDH, Merck Chemicals 
Ltd., Nottingham, England, UK), with a final 
pH 7.2, was prepared and isolates were 
streaked on the plates and incubated for 48 
hours at 37
o
C. The plates were observed for 
growth and subsequently flooded with 10 ml of 
a Frazier’s solution (mercuric chloride, 15.0 g 
in 20 ml of 37%v/v hydrochloric acid, made up 
to 100 ml with distilled water). The plates 
which showed area of opaque layer with zone 
of clearance around the colonies were taken as 
positive for gelatin hydrolysis. 
 
2.2.2 Detection of Haemolysin Produc-
tion: Brain heart infusion agar (Oxoid) 
supplemented with 5% human blood was used 
for the detection of haemolysin activity. 
Prepared plates were streaked with the isolates 
and incubated at 37
o
C for 24 hours. Haemolytic 
activity was observed as β-haemolysis 
surrounding bacterial colonies in the plates. 
 
2.3 Haemagglutination Test 
Enterococcal isolates were cultivated in 
10 ml of Brain Heart Infusion agar (Oxoid) for 
24 hours at 37
o
C. The isolates were grown in 
peptone water, and thereafter concentrated by 
centrifugation at 3,500 rpm for 10 min at 4
o
C. 
The bacterial pellet was washed twice in 0.002 
M phosphate buffered saline (PBS) (pH 6.8) 
and suspended in 5 ml of the same buffer. Red 
blood cells (RBCs) were obtained from human 
blood by centrifugation at 3,000 rpm for 10 
min., washed and re-suspended in PBS 
containing 0.1% ethylenediaminetetraacetic 
acid (EDTA). Haemagglutination tests were 
AU J.T. 16(4): 247-254 (Apr. 2013) 
Technical Report 249 
carried out by mixing 10-μl bacterial 
suspension with 20 μl of 2% harvested human 
RBCs on a slide, being rotated gently, read and 
observed for agglutination within 30 s 
according to Gülhan et al. (2006). 
 
2.4 Antibiotic Sensitivity Testing 
The isolates were grown at 37°C in 
Mueller-Hilton broth (Oxoid) for 18 hours and 
standardized according to the Clinical and 
Laboratory Standard Institute, Wayne, PA, 
USA (CLSI 2005). The susceptibility of the 
isolates was determined by the disc diffusion 
method as described by CLSI (2005). The 
following antibiotics (Oxoid) with their 
concentrations (in μg) were used: 
chloramphenicol (30), cotrimoxazole (25), 
amoxycilin-clavulanic acid (30), cefuroxime 
(30), ampicillin (10), erythromycin (15), 
nitrofurantoin (300), tetracycline (30), 




Three types of clinical samples were 
studied with one environmental sample in this 
study. The clinical samples included stool (n = 
57), wound swab (n = 15) and high vaginal 
swab (n = 9), while 35 hospital bed sheets 
(environmental samples) were examined. Five 
species of the genus Enterococcus were 
isolated, characterized and identified (Table 1). 
The species isolated and identified include: E. 
faecalis (110), E. faecium (75), E. gallinarum 
(39), E. durans (37) and E. hirae (33). E. 
faecalis was most frequently isolated followed 
by E. faecium while E. hirae had the least 
occurrence.  
The isolates were tested for the presence 
of virulence factors. The factors examined were 
cytolysin (Cyt), gelatinase (Gel) and 
haemaglutinin (Hae). The results are shown in 
Table 2. The occurrence of the virulence factor 
was very prominent in E. faecalis, E. faecium 
and E. gallinarum. Cytolysin (Cyt) was most 
observed in E. gallinarum (74.4%) followed by 
E. faecalis (68.5%). For Gel, E. faecium had 
the highest occurrence (64.0%) followed by E. 
gallinarum (61.5%) while E. hirae (24.2%) had 
the least among the identified species. A total 
of 49 (44.1%), 19 (48.7%) and 13 (17.3%) 
among E. faecalis, E. gallinarum and E. 
faecium, respectively, were positive for the 
combination of Cyt and Gel. The number of 
isolates with combinations of Gel and Hea was 
comparably lower than the Cyt and Gel 
combination. The detection of the three 
virulence factors is in this decreasing order: E. 
faecalis 20 (18.0%), E. faecium 8 (10.7%) and 
E. gallinarum 2 (5.1%)  
Nine antibiotics were tested against the 
isolates to determine their susceptibilities 
(Table 3). All the E. faecium strains were 
resistant to cotrimoxazole, ampicillin and 
chloramphenicol, and none were resistant to 
vancomycin. Ofloxacin was effective against E. 
faecalis with a percentage resistance of 27.9% 
while the highest resistance was observed 
against cotrimoxazole. Vancomycin and 
nitrofurantoin, in decreasing order, had better 
inhibitory effects on the pathogens. 
Enterococcus gallinarum was the most 
susceptible among the species. Based on 
percentage resistance of the isolates, the least 
effective antibiotics are: cotrimoxazole > 
erythromycin > ampicillin > chloramphenicol 




Among the enterococci isolates recovered 
in this study, E. faecalis and E. faecium 
occurred in high percentage (94.9% and 64.7%, 
respectively). Similar trend has been reported 
by Fatholahzadeh et al. (2006), Baragundi et 
al. (2010) and Olawale et al. (2011). However, 
Fatholahzadeh et al. (2006) and Olawale et al. 
(2011) did not isolate E. durans and E. hirae. 
This points out the increased clinical 
importance of Enterococcus species other than 
E. faecalis and E. faecium. Fourteen of the 
isolates were not characterized beyond the 
generic level.  
The virulence traits found in the isolates 
have been considered as possible factors 
described to play important roles in making 
enterococci potential pathogens (Mäkinen et al. 
1989; Eaton and Gasson 2001; Toledo-Arana et 
al. 2001). 
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n = 57 (%) 
Wound 
swab 
n = 15 (%) 
High 
vaginal 
n = 9 (%) 
Hospital 
bed sheet 
n = 35 (%) 
Total 
n = 116 (%) 
E. faecalis 56 (98.3) 15 (100.0) 6(66.7) 33 (94.3) 110 (94.8) 
E. faecium 43 (75.4) 10 (66.7) 1(11.1) 21(60.0) 75 (64.7) 
E. gallinarum 21 (36.8) 2(13.3) 0 16 (45.7) 39 (33.6) 
E. durans 14 (24.56) 4 (26.7) 2 (22.2) 17 (48.6) 37 (31.9) 
E. hirae 10 (17.5) 8 (53.3) 1 (11.1) 14 (40.0) 33 (28.5) 
Enterococcus spp 5 (8.8) 6 (40.0) 1 (11.1) 2(5.7) 14 (12.1) 
 
 






n = 111 (%) 
E. faecium 
n = 75 (%) 
E. gallinarum 
n = 39 (%) 
E. durans 
n = 37 (%) 
E. hirae 
n = 33 (%) 
Enterococcus 
spp. 
n = 14 (%) 
Cyt 76 (68.5) 39(52.0) 29 (74.4) 5(13.5) 6(18.2) 2(14.3) 
Gel 71 (64.0) 28 (37.3) 24 (61.5) 12 (32.4) 8 (24.2) 2 (14.3) 
Hae 40 (36.0) 36 (48.0) 5 (12.8) 6 (16.2) 5 (15.2) 1 (7.1) 
Cyt+Gel 49 (44.1) 13 (17.3) 19 (48.7) 3 (8.1) 3 (9.1) 2 (14.3) 
Cyt+Hea 25 (22.5) 23 (30.7) 5 (12.8) 2 (5.4) 4 (12.1) 1 (7.1) 
Gel+Hea 30 (27.0) 17 (22.7) 2 (5.1) 3 (8.1) 2 (6.1) 1 (7.1) 
Cyt+Gel+Hea 20 (18.0) 8 (10.7) 2 (5.1) 1(2.7) 1 (3.0) 0 
 
 

















COT 98(88.3) 75 (100.0) 39 (100.0) 35 (94.6) 31 (93.9) 14 (100.0) 
AMP 89 (80.2) 75 (100.0) 31 (79.5) 33 (89.2) 29 (87.9) 14 (100.0) 
CHL 92 (82.9) 75 (100.0) 16 (41.0) 31 (83.8) 26 (78.8) 12 (85.7) 
TET 71 (64.0) 46 (61.3) 23 (59.0) 27 (73.0) 22 (66.7) 12 (78.6) 
CEF 80 (72.1) 45 (60.0) 16 (41.0) 32 (86.5) 27 (81.3) 11 (78.6) 
AMOX/CLAV 78 (70.3) 61(81.3) 23 (59.0) 31 (83.8) 23 (69.7) 9 (64.3) 
ERY 77 (69.4) 75 (100.0) 31 (79.5) 35 (94.6) 32 (97.0) 14 (100.0) 
NIT 62 (55.9) 44 (58.7) 15 (38.5) 28 (75.7) 21 (63.6) 8 (57.1) 
OFL 31 (27.9) 39 (52.0) 17 (43.6) 12 (32.4) 10 (30.3) 4(28.6) 
VAN 34 (30.6) 0 (0) 2 (5.1) 4 (10.8) 6 (18.2) 0 (0) 
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Haemolysin is a plasmid-encoded toxin 
produced by beta-haemolytic E. faecalis. Its 
lysis erythrocytes, polymorphonuclear 
neutrophils (PMN) and macrophages kill 
bacterial cells and may lead to reduced 
phagocytosis (Ike et al. 1992). The 
enterococcal infections caused due to the 
potential virulence factors are difficult to treat 
(Huycke and Gilmore 1997). Mundy et al. 
(2000), Ghoshal et al. (2006) and Agrawal et 
al. (2009) have reported earlier the spread of 
antimicrobial resistance and virulence markers 
among clinical isolates. The wide spread of the 
virulence-marker-borne strains may be as a 
result of evolution (Eaton and Gasson 2001) or 
exchange of genetic materials between the 
enterococci in the ecosystem (Dunny and 
Clewell 1975). 
In this study, some strains of E. faecium 
isolates were positive for gelatinase production. 
However, Kanemitsu et al. (2001) has reported 
earlier E. faecium isolates to possess gelatinase. 
In this study, there was a reasonable 
distribution of virulence markers in 
Enterococcus species isolated from clinical and 
environmental samples. This supports the 
earlier reports that virulence markers are 
common traits among genus Enterococcus 
from clinical samples (Jett et al. 1994; Semedo 
et al. 2003; Macovei et al. 2009) and the 
environment (Coque et al. 1995; 1996). These 
virulence factors permit adherence to host cells 
and extracellular matrix, facilitate tissue 
invasion, affect immunomodulation and cause 
toxin-mediated damage. (Kristich et al. 2004; 
Ahmadova et al. 2013). 
All the E. faecium strains were resistant 
to cotrimozazole, ampicillin and 
chloramphenicol while none were resistant to 
vancomycin. This report is in agreement with 
the findings of Chayakul et al. (2007) and 
Rudy et al. (2004) who reported no resistance 
to vancomycin among E. faecium. The majority 
of the vancomycin-resistant enterococci (VRE) 
was found among E. faecalis (30.6%) followed 
by E. durans (18.1%) which is similar to the 
report of Fatholahzadeh et al. (2006). To the 
best knowledge of the authors, this is the first 
report of vancomycin resistance among strains 
of E. durans in Nigeria. The case of 
vancomycin resistance (30.6%) among the E. 
faecalis strains in this study shows that the 
epidemiology of enterococci is changing in 
southwestern Nigeria. Olawale et al. (2011) 
reported 42.9% vancomycin resistance among 
enterococci while David (2010) reported 17.4% 
resistance to vancomycin among E. faecalis 
isolates. The vancomycin-resistant enterococci 
probably represent the most serious challenge 
among many microbes with antibiotic 
resistance as a source of human clinical 
infections. Enterococci have the ability to 
transfer plasmids to both closely and distantly 
related Gram-positive bacteria (Clewell 1993; 
Bøhle et al. 2011). In addition, the recent 
appearance and increase of antibiotic-resistant 
and, notably, vancomycin-resistant enterococci 
poses a serious clinical problem. Resistance to 
antibiotics commonly leads to a failure of 
treatment with other antimicrobials. Most 
enterococcal isolates in this study possessed at 
least one virulence factor and were also 
resistant to various antimicrobials. This may be 
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